Ligand-Receptor Binding and Tissue Response

Pharmacology: Principles and Practice

Volumn , Issue , 2009, Pages 63-74

  Kenakin, Terry ^a  

^a GLAXOSMITHKLINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84883452229     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-369521-5.00004-X     Document Type: Chapter

References (9)

1. J.W. Black and P. Leff (1983) Operational models of pharmacological agonist. Proceedings of the Royal Society of London [Biol] 220 141.
2. A.S.V. Burgen (1981) Conformational changes and drug action. Federal Proceedings 40 2723-2728.
3. T.P. Kenakin (2001) Inverse, protean, and ligand-selective agonism: Matters of receptor conformation. The FASEB Journal 15 598-611.
4. T.P. Kenakin (2004) A Pharmacology Primer: Theory, Application and Methods Amsterdam: Academic Press/ Elsevier 1-324.
5. T.P. Kenakin (2004) Principles: Receptor theory in pharmacology. Trends in Pharmacological Sciences 25 186-192.
6. J.N.C. Kew, G. Trube and J.A. Kemp (1996) A novel mechanism of activity-dependent NMDA receptor antagonism describes the effect of ifenprodil in rat cultured cortical neurons. Journal of Physiology 3 761-772. 497
7. H.P. Rang (2006) The receptor concept: Pharmacology's big idea. British Journal of Pharmacology 147 S9.
8. P. Samama, S. Cotecchia, T. Costa and R.J. Lefkowitz (1993) A mutation-induced activated state of the β2-adrenergic receptor: Extending the ternary complex model. The Journal of Biological Chemistry 268 4625-4636.
9. R.P. Stephenson (1956) A modification of receptor theory. British Journal of Pharmacology 11 379-393.